tetano
Editor, Senior Moderator
mBio
. 2023 May 24;e0051923.
doi: 10.1128/mbio.00519-23. Online ahead of print. Memory Th17 cell-mediated protection against lethal secondary pneumococcal pneumonia following influenza infection
Yong Li[SUP] #[/SUP][SUP] 1 2 [/SUP], Ying Yang[SUP] #[/SUP][SUP] 1 [/SUP], Dafan Chen[SUP] #[/SUP][SUP] 1 3 [/SUP], Yan Wang[SUP] #[/SUP][SUP] 1 [/SUP], Xinyun Zhang[SUP] 1 4 [/SUP], Wenchao Li[SUP] 1 [/SUP], Shengsen Chen[SUP] 1 5 [/SUP], Sandy M Wong[SUP] 6 [/SUP], Mengwen Shen[SUP] 1 7 [/SUP], Brian J Akerley[SUP] 8 [/SUP], Hao Shen[SUP] 1 [/SUP]
Affiliations
Streptococcus pneumoniae (Sp) frequently causes secondary pneumonia after influenza A virus (IAV) infection, leading to high morbidity and mortality worldwide. Concomitant pneumococcal and influenza vaccination improves protection against coinfection but does not always yield complete protection. Impaired innate and adaptive immune responses have been associated with attenuated bacterial clearance in influenza virus-infected hosts. In this study, we showed that preceding low-dose IAV infection caused persistent Sp infection and suppression of bacteria-specific T-helper type 17 (Th17) responses in mice. Prior Sp infection protected against subsequent IAV/Sp coinfection by improving bacterial clearance and rescuing bacteria-specific Th17 responses in the lungs. Furthermore, blockade of IL-17A by anti-IL-17A antibodies abrogated the protective effect of Sp preinfection. Importantly, memory Th17 responses induced by Sp preinfection overcame viral-driven Th17 inhibition and provided cross-protection against different Sp serotypes following coinfection with IAV. These results indicate that bacteria-specific Th17 memory cells play a key role in providing protection against IAV/Sp coinfection in a serotype-independent manner and suggest that a Th17-based vaccine would have excellent potential to mitigate disease caused by coinfection.IMPORTANCEStreptococcus pneumoniae (Sp) frequently causes secondary bacterial pneumonia after influenza A virus (IAV) infection, leading to increased morbidity and mortality worldwide. Current pneumococcal vaccines induce highly strain-specific antibody responses and provide limited protection against IAV/Sp coinfection. Th17 responses are broadly protective against Sp single infection, but whether the Th17 response, which is dramatically impaired by IAV infection in naïve mice, might be effective in immunization-induced protection against pneumonia caused by coinfection is not known. In this study, we have revealed that Sp-specific memory Th17 cells rescue IAV-driven inhibition and provide cross-protection against subsequent lethal coinfection with IAV and different Sp serotypes. These results indicate that a Th17-based vaccine would have excellent potential to mitigate disease caused by IAV/Sp coinfection.
Keywords: Streptococcus pneumoniae; Th17 responses; coinfection; cross-protection; influenza A virus.
. 2023 May 24;e0051923.
doi: 10.1128/mbio.00519-23. Online ahead of print. Memory Th17 cell-mediated protection against lethal secondary pneumococcal pneumonia following influenza infection
Yong Li[SUP] #[/SUP][SUP] 1 2 [/SUP], Ying Yang[SUP] #[/SUP][SUP] 1 [/SUP], Dafan Chen[SUP] #[/SUP][SUP] 1 3 [/SUP], Yan Wang[SUP] #[/SUP][SUP] 1 [/SUP], Xinyun Zhang[SUP] 1 4 [/SUP], Wenchao Li[SUP] 1 [/SUP], Shengsen Chen[SUP] 1 5 [/SUP], Sandy M Wong[SUP] 6 [/SUP], Mengwen Shen[SUP] 1 7 [/SUP], Brian J Akerley[SUP] 8 [/SUP], Hao Shen[SUP] 1 [/SUP]
Affiliations
- PMID: 37222516
- DOI: 10.1128/mbio.00519-23
Streptococcus pneumoniae (Sp) frequently causes secondary pneumonia after influenza A virus (IAV) infection, leading to high morbidity and mortality worldwide. Concomitant pneumococcal and influenza vaccination improves protection against coinfection but does not always yield complete protection. Impaired innate and adaptive immune responses have been associated with attenuated bacterial clearance in influenza virus-infected hosts. In this study, we showed that preceding low-dose IAV infection caused persistent Sp infection and suppression of bacteria-specific T-helper type 17 (Th17) responses in mice. Prior Sp infection protected against subsequent IAV/Sp coinfection by improving bacterial clearance and rescuing bacteria-specific Th17 responses in the lungs. Furthermore, blockade of IL-17A by anti-IL-17A antibodies abrogated the protective effect of Sp preinfection. Importantly, memory Th17 responses induced by Sp preinfection overcame viral-driven Th17 inhibition and provided cross-protection against different Sp serotypes following coinfection with IAV. These results indicate that bacteria-specific Th17 memory cells play a key role in providing protection against IAV/Sp coinfection in a serotype-independent manner and suggest that a Th17-based vaccine would have excellent potential to mitigate disease caused by coinfection.IMPORTANCEStreptococcus pneumoniae (Sp) frequently causes secondary bacterial pneumonia after influenza A virus (IAV) infection, leading to increased morbidity and mortality worldwide. Current pneumococcal vaccines induce highly strain-specific antibody responses and provide limited protection against IAV/Sp coinfection. Th17 responses are broadly protective against Sp single infection, but whether the Th17 response, which is dramatically impaired by IAV infection in naïve mice, might be effective in immunization-induced protection against pneumonia caused by coinfection is not known. In this study, we have revealed that Sp-specific memory Th17 cells rescue IAV-driven inhibition and provide cross-protection against subsequent lethal coinfection with IAV and different Sp serotypes. These results indicate that a Th17-based vaccine would have excellent potential to mitigate disease caused by IAV/Sp coinfection.
Keywords: Streptococcus pneumoniae; Th17 responses; coinfection; cross-protection; influenza A virus.